Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial.
Ann Oncol
; 33(7): 685-692, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35395383
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sarcopenia
/
Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2022
Type:
Article